Noncontrast Myocardial T1 Mapping by Cardiac Magnetic Resonance Predicts Outcome in Patients With Aortic Stenosis

JACC: Cardiovascular Imaging

Volumn 11, Issue 7, 2018, Pages 974-983

  Lee, Heesun ^a,b   Park, Jun Bean ^a,c   Yoon, Yeonyee E ^a,d   Park, Eun Ah ^c   Kim, Hyung Kwan ^a,c   Lee, Whal ^c   Kim, Yong Jin ^a,c   Cho, Goo Yeong ^a,d   Sohn, Dae Won ^a,c   Greiser, Andreas ^e   Lee, Seung Pyo ^a,c  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Seoul National University Hospital   (South Korea)

^d Seoul National University Bundang Hospital   (South Korea)

^e SIEMENS AG   (Germany)

Author keywords

aortic stenosis; cardiac magnetic resonance; native T1 mapping; prognosis

Indexed keywords

AGED; AORTIC STENOSIS; ARTICLE; CARDIAC MUSCLE; CARDIOVASCULAR MAGNETIC RESONANCE; CAUSE OF DEATH; CLINICAL OUTCOME; CONTROLLED STUDY; EUROSCORE; FEMALE; FOLLOW UP; HEART FAILURE; HEART MUSCLE FIBROSIS; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; TRANSCATHETER AORTIC VALVE IMPLANTATION; AORTIC VALVE STENOSIS; CASE CONTROL STUDY; COMPLICATION; DIAGNOSTIC IMAGING; FIBROSIS; HOSPITALIZATION; MIDDLE AGED; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PREDICTIVE VALUE; PROGNOSIS; RISK FACTOR; SEVERITY OF ILLNESS INDEX; TIME FACTOR;

AGED; AORTIC VALVE STENOSIS; CASE-CONTROL STUDIES; CAUSE OF DEATH; FEMALE; FIBROSIS; HEART FAILURE; HOSPITALIZATION; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIUM; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 85034454820     PISSN: 1936878X     EISSN: 18767591     Source Type: Journal    
DOI: 10.1016/j.jcmg.2017.09.005     Document Type: Article

References (38)

1. Bonow, R.O., Greenland, P., Population-wide trends in aortic stenosis incidence and outcomes. Circulation 131 (2015), 969–971.
2. Hein, S., Arnon, E., Kostin, S., et al. Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms. Circulation 107 (2003), 984–991.
3. Krayenbuehl, H.P., Hess, O.M., Monrad, E.S., et al. Left ventricular myocardial structure in aortic valve disease before, intermediate, and late after aortic valve replacement. Circulation 79 (1989), 744–755.
4. Milano, A.D., Faggian, G., Dodonov, M., et al. Prognostic value of myocardial fibrosis in patients with severe aortic valve stenosis. J Thorac Cardiovasc Surg 144 (2012), 830–837.
5. Dweck, M.R., Joshi, S., Murigu, T., et al. Midwall fibrosis is an independent predictor of mortality in patients with aortic stenosis. J Am Coll Cardiol 58 (2011), 1271–1279.
6. Azevedo, C.F., Nigri, M., Higuchi, M.L., et al. Prognostic significance of myocardial fibrosis quantification by histopathology and magnetic resonance imaging in patients with severe aortic valve disease. J Am Coll Cardiol 56 (2010), 278–287.
7. Mewton, N., Liu, C.Y., Croisille, P., et al. Assessment of myocardial fibrosis with cardiovascular magnetic resonance. J Am Coll Cardiol 57 (2011), 891–903.
8. Rogers, T., Yap, M.L., Puntmann, V.O., Myocardial T1 mapping: a non-invasive alternative to tissue diagnosis?. Eur Heart J Cardiovasc Imaging 16 (2015), 108–109.
9. Barone-Rochette, G., Pierard, S., De Meester de Ravenstein, C., et al. Prognostic significance of LGE by CMR in aortic stenosis patients undergoing valve replacement. J Am Coll Cardiol 64 (2014), 144–154.
10. Flett, A.S., Sado, D.M., Quarta, G., et al. Diffuse myocardial fibrosis in severe aortic stenosis: an equilibrium contrast cardiovascular magnetic resonance study. Eur Heart J Cardiovasc Imaging 13 (2012), 819–826.
11. Ugander, M., Oki, A.J., Hsu, L.Y., et al. Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology. Eur Heart J 33 (2012), 1268–1278.
12. Puntmann, V.O., Voigt, T., Chen, Z., et al. Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy. J Am Coll Cardiol Img 6 (2013), 475–484.
13. Lee, S.P., Lee, W., Lee, J.M., et al. Assessment of diffuse myocardial fibrosis by using MR imaging in asymptomatic patients with aortic stenosis. Radiology 274 (2015), 359–369.
14. Bull, S., White, S.K., Piechnik, S.K., et al. Human non-contrast T1 values and correlation with histology in diffuse fibrosis. Heart 99 (2013), 932–937.
15. Nishimura, R.A., Otto, C.M., Bonow, R.O., et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 63 (2014), 2438–2488.
16. Seo, H.Y., Lee, S.P., Park, J.B., et al. Discrepancies in left ventricular mass calculation based on echocardiography and cardiovascular magnetic resonance measurements in patients with left ventricular hypertrophy. J Am Soc Echocardiogr 28 (2015), 1194–1203 e2.
17. Kramer, C.M., Barkhausen, J., Flamm, S.D., et al. Standardized cardiovascular magnetic resonance imaging (CMR) protocols, Society for Cardiovascular Magnetic Resonance: Board of Trustees Task Force on Standardized Protocols. J Cardiovasc Magn Reson, 10, 2008, 35.
18. Messroghli, D.R., Radjenovic, A., Kozerke, S., et al. Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Magn Reson Med 52 (2004), 141–146.
19. Rogers, T., Dabir, D., Mahmoud, I., et al. Standardization of T1 measurements with MOLLI in differentiation between health and disease–the ConSept study. J Cardiovasc Magn Reson, 15, 2013, 78.
20. Lee, S.P., Park, S.J., Kim, Y.J., et al. Early detection of subclinical ventricular deterioration in aortic stenosis with cardiovascular magnetic resonance and echocardiography. J Cardiovasc Magn Reson, 15, 2013, 7221.
21. Vittinghoff, E., McCulloch, C.E., Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol 165 (2007), 710–718.
22. DeLong, E.R., DeLong, D.M., Clarke-Pearson, D.L., Comparing areas under two or more correlated receiver operating characteristics curves: a nonparamentric approach. Biometrics 44 (1988), 837–845.
23. Díez, J., Querejeta, R., López, B., et al. Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients. Circulation 105 (2002), 2512–2517.
24. Weber, K.T., Brilla, C.G., Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation 83 (1991), 1849–1865.
25. Everett, R.J., Stirrat, C.G., Semple, S.I., et al. Assessment of myocardial fibrosis with T1 mapping MRI. Clin Radiol 71 (2016), 768–778.
26. Nguyen, C., Lu, M., Fan, Z., et al. Contrast-free detection of myocardial fibrosis in hypertrophic cardiomyopathy patients with diffusion-weighted cardiovascular magnetic resonance. J Cardiovasc Magn Reson, 17, 2015, 107.
27. Kali, A., Choi, E.Y., Sharif, B., et al. Native T1 mapping by 3-T CMR imaging for characterization of chronic myocardial infarctions. J Am Coll Cardiol Img 8 (2015), 1019–1030.
28. Osnabrugge, R.L., Mylotte, D., Head, S.J., et al. Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study. J Am Coll Cardiol 62 (2013), 1002–1012.
29. Singh, A., Horsfield, M.A., Bekele, S., et al. Myocardial T1 and extracellular volume fraction measurement in asymptomatic patients with aortic stenosis: reproducibility and comparison with age-matched controls. Eur Heart J Cardiovasc Imaging 16 (2015), 763–770.
30. McLellan, A.J., Ling, L.H., Azzopardi, S., et al. Diffuse ventricular fibrosis measured by T(1) mapping on cardiac MRI predicts success of catheter ablation for atrial fibrillation. Circ Arrhythm Electrophysiol 7 (2014), 834–840.
31. Banypersad, S.M., Fontana, M., Maestrini, V., et al. T1 mapping and survival in systemic light-chain amyloidosis. Eur Heart J 36 (2015), 244–251.
32. Puntmann, V.O., Carr-White, G., Jabbour, A., et al. T1-mapping and outcome in nonischemic cardiomyopathy: all-cause mortality and heart failure. J Am Coll Cardiol Img 9 (2016), 40–50.
33. Nadjiri, J., Nieberler, H., Hendrich, E., et al. Prognostic value of T1-mapping in TAVR patients: extra-cellular volume as a possible predictor for peri- and post-TAVR adverse events. Int J Cardiovasc Imaging 32 (2016), 1625–1633.
34. Kang, D.H., Park, S.J., Rim, J.H., et al. Early surgery versus conventional treatment in asymptomatic very severe aortic stenosis. Circulation 121 (2010), 1502–1509.
35. Mahmod, M., Piechnik, S.K., Levelt, E., et al. Adenosine stress native T1 mapping in severe aortic stenosis: evidence for a role of the intravascular compartment on myocardial T1 values. J Cardiovasc Magn Reson, 16, 2014, 92.
36. Schoenfeld, D.A., Sample-size formula for the proportional hazards regression model. Biometrics 39 (1983), 499–503.
37. Hsieh, F.Y., Lavori, P.W., Sample-size calculations for the Cox proportional hazards regression model with nonbinary covariates. Control Clin Trials 21 (2000), 552–560.
38. Treibel, T.A., Fontana, M., Maestrini, V., et al. Automatic measurement of the myocardial interstitium: synthetic extracellular volume quantification without hematocrit sampling. J Am Coll Cardiol Img 9 (2016), 54–63.